T. Rowe Price Associates’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $82K | Hold |
|
|||||
|
2025
Q2 | $113K | Buy |
|
|||||
|
2025
Q1 | $124K | Buy |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q3 | $130K | Hold |
|
|||||
|
2024
Q2 | $131K | Buy |
|
|||||
|
2024
Q1 | $106K | Buy |
|
|||||
|
2023
Q4 | $99K | Buy |
|
|||||
|
2023
Q3 | $59K | Buy |
|
|||||
|
2023
Q2 | $84K | Buy |
|
|||||
|
2023
Q1 | $83K | Buy |
|
|||||
|
2022
Q4 | $83K | Buy |
|
|||||
|
2022
Q3 | $88K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $259K | Sell |
|
|||||
|
2021
Q4 | $5.67M | Buy |
|
|||||
|
2021
Q3 | $6.12M | Buy |
|